TearScience’s Boorady Touts LipiFlow’s Duration

Joseph Boorady, president and CEO, TearScience, shares details on recent studies that demonstrated LipiFlow’s ability to deliver long-term relief for dry eye sufferers. He also reveals some exciting early commercial success.


Joseph Boorady

Joseph Boorady

Joe Boorady serves as President and CEO of TearScience and has spent over 20 years in the ophthalmic industry as an executive.

View Full Profile